Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Comparing Treatments for Multiple Myeloma
ClinicalTrials.gov study NCT00001750. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT00555100. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00416208. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT03135925. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02197221. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)
ClinicalTrials.gov study NCT00702247. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03287908. IPD Sharing: YES. Countries: 6. Publications: 1.
Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients
ClinicalTrials.gov study NCT01440582. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
ClinicalTrials.gov study NCT02465060. IPD Sharing: Not stated. Countries: 3. Publications: 13.
Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma
ClinicalTrials.gov study NCT02800954. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00006890. IPD Sharing: NO. Countries: 2. Publications: 1.
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
ClinicalTrials.gov study NCT01093196. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse
ClinicalTrials.gov study NCT01217203. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)
ClinicalTrials.gov study NCT01279694. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
ClinicalTrials.gov study NCT01002248. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
ClinicalTrials.gov study NCT02851056. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
ClinicalTrials.gov study NCT00339963. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
ClinicalTrials.gov study NCT05652335. IPD Sharing: YES. Countries: 7. Publications: 1.
Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients
ClinicalTrials.gov study NCT02970747. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
ClinicalTrials.gov study NCT00063726. IPD Sharing: Not stated. Countries: 13. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.